Intranasal administration of oxytocin in children and young adults with Prader-Willi Syndrome. A randomized, double-blind, placebo-controlled trial. Effects on satiety and food intake, and social behaviour.
Phase of Trial: Phase III
Latest Information Update: 11 May 2017
Price : $35 *
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 May 2017 Status changed from recruiting to completed.
- 26 Feb 2015 New source identified and integrated (Netherlands Trial Register; NTR4950)